CAR-T: a potential gene carrier targeting solid tumor immune microenvironment

Código QR

CAR-T: a potential gene carrier targeting solid tumor immune microenvironment

Guardado en:

Detalles Bibliográficos
Autores principales:	Minjie Wang, Chaocai Zhang, Xiaobing Jiang
Formato:	article
Lenguaje:	EN
Publicado:	Nature Publishing Group 2021
Materias:	Medicine R Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/af09160823274bc0a0cbed60cbde9dd6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

NGAL as a Potential Target in Tumor Microenvironment
por: Elvira Crescenzi, et al.
Publicado: (2021)

Synthetic promoters to induce immune-effectors into the tumor microenvironment
por: Yariv Greenshpan, et al.
Publicado: (2021)

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
por: Xiaopei Hao, et al.
Publicado: (2021)

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors
por: Amanda Rosewell Shaw, et al.
Publicado: (2021)

Emerging Approaches for Solid Tumor Treatment Using CAR-T Cell Therapy
por: Hyunmin Chung, et al.
Publicado: (2021)

Multiplexed imaging analysis of the tumor-immune microenvironment reveals predictors of outcome in triple-negative breast cancer
por: Aalok Patwa, et al.
Publicado: (2021)

Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments
por: Gautam N. Shenoy, et al.
Publicado: (2021)

Multimodal Imaging-Based Potential Visualization of the Tumor Microenvironment in Bone Metastasis
por: Jang Bae Moon, et al.
Publicado: (2021)

In silico experimentation of glioma microenvironment development and anti-tumor therapy.
por: Yu Wu, et al.
Publicado: (2012)

Intrabody Targeting HIF-1α Mediates Transcriptional Downregulation of Target Genes Related to Solid Tumors
por: Yaozhong Hu, et al.
Publicado: (2021)

Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma
por: Bin Zheng, et al.
Publicado: (2021)

Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma
por: Jiyuan Xing, et al.
Publicado: (2021)

A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells
por: Jacqui A. McGovern, et al.
Publicado: (2021)

A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment
por: Susanna S. Ng, et al.
Publicado: (2021)

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
por: Husam Babikir, et al.
Publicado: (2021)

Developing ovine mammary terminal duct lobular units have a dynamic mucosal and stromal immune microenvironment
por: Dorottya Nagy, et al.
Publicado: (2021)

Molecularly targeted photothermal ablation improves tumor specificity and immune modulation in a rat model of hepatocellular carcinoma
por: Nina M. Muñoz, et al.
Publicado: (2020)

The Metabolic Control of Myeloid Cells in the Tumor Microenvironment
por: Eloise Ramel, et al.
Publicado: (2021)

Molecular Characterization of the Clinical and Tumor Immune Microenvironment Signature of 5-methylcytosine-Related Regulators in non-small Cell Lung Cancer
por: Taisheng Liu, et al.
Publicado: (2021)

Kaiso (ZBTB33) subcellular partitioning functionally links LC3A/B, the tumor microenvironment, and breast cancer survival
por: Sandeep K. Singhal, et al.
Publicado: (2021)

Hedgehog Pathway Inhibitors against Tumor Microenvironment
por: Silpa Gampala, et al.
Publicado: (2021)

Multiscale modeling of tumor growth and angiogenesis: Evaluation of tumor-targeted therapy.
por: Sahar Jafari Nivlouei, et al.
Publicado: (2021)

Increased expression of peptides from non-coding genes in cancer proteomics datasets suggests potential tumor neoantigens
por: Rong Xiang, et al.
Publicado: (2021)

Editorial to the Special Issue “MicroRNA in Solid Tumor and Hematological Diseases”
por: Francesca Lovat
Publicado: (2021)

Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma
por: Alexander A. Strait, et al.
Publicado: (2021)

Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?
por: Anna Maria Corsale, et al.
Publicado: (2021)

Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
por: Wentao Tian, et al.
Publicado: (2021)

The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
por: Rodion A. Velichinskii, et al.
Publicado: (2021)

Pyroptosis-Mediated Molecular Subtypes and Tumor Microenvironment Infiltration Characterization in Colon Cancer
por: Jiawei Rao, et al.
Publicado: (2021)

Differential Role of PD-1 Expressed by Various Immune and Tumor Cells in the Tumor Immune Microenvironment: Expression, Function, Therapeutic Efficacy, and Resistance to Cancer Immunotherapy
por: Myeong Joon Kim, et al.
Publicado: (2021)

A single-chain antibody generation system yielding CAR-T cells with superior antitumor function
por: Toshiki Ochi, et al.
Publicado: (2021)

Dynamics and potential impact of the immune response to chronic myelogenous leukemia.
por: Peter S Kim, et al.
Publicado: (2008)

Atonal homolog 1 is a tumor suppressor gene.
por: Wouter Bossuyt, et al.
Publicado: (2009)

Identification of Clinical and Tumor Microenvironment Characteristics of Hypoxia-Related Risk Signature in Lung Adenocarcinoma
por: Zili Dai, et al.
Publicado: (2021)

From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma
por: Jonathan Anker, et al.
Publicado: (2021)

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Christopher Sloas, et al.
Publicado: (2021)

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Su Chul Jang, et al.
Publicado: (2021)

Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens
por: Romain Darrigrand, et al.
Publicado: (2021)

Optimal combination treatment regimens of vaccine and radiotherapy augment tumor-bearing host immunity
por: Fayun Zhang, et al.
Publicado: (2021)

Integrating m6A Regulators-Mediated Methylation Modification Models and Tumor Immune Microenvironment Characterization in Caucasian and Chinese Low-Grade Gliomas
por: Wangrui Liu, et al.
Publicado: (2021)